Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BDA-366 |
Trade Name | |
Synonyms | |
Drug Descriptions |
BDA-366 is a small molecule selective inhibitor of BCL2 that targets the BH4 domain and induces pro-apoptotic activity, potentially resulting in increased tumor cell apoptosis (PMID: 26004684, PMID: 30047840). |
DrugClasses | BCL2 inhibitor 27 |
CAS Registry Number | 1909226-00-1 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BDA-366 | BDA-366 | 0 | 0 |
BDA-366 + Everolimus | BDA-366 Everolimus | 0 | 0 |